CSNK2A1 and ovarian cancer: Compared to non-targeting siRNAs, peptide DIV3W induced up to 94% suppression of CSNK2A1 mRNA and showed effective transport of bioactive siRNAs into ovarian cancer cells with high cellular uptake efficiency, which reduced cell migration and recolonization in vitro.